Search Within

Maureen F Zakowski

Formats
  1. Meeting Abstract (143)
  2. Journal Article (141)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Department of Pathology and Laboratory Medicine (166)
  2. GSK Faculty (121)
  3. Department of Medicine (117)
  4. Human Oncology and Pathogenesis Program (115)
  5. Tow Center for Developmental Oncology (TCDO) (115)
  6. Solid Tumor Oncology Division (112)

More Groups

People
  1. Marc Ladanyi (113)
  2. Mark Kris (90)
  3. Valerie Rusch (65)
  4. William Pao (51)
  5. Vincent Miller (46)
  6. Gregory Riely (45)

More People

Years
  1. 2016 (4)
  2. 2015 (7)
  3. 2014 (9)
  4. 2013 (12)
  5. 2012 (21)
  6. 2011 (19)

More Years

Publications
  1. Modern Pathology (42)
  2. Laboratory Investigation (37)
  3. Journal of Clinical Oncology (29)
  4. Journal of Thoracic Oncology (27)
  5. Diagnostic Cytopathology (16)
  6. Cancer Cytopathology (15)

More Publications

Publishers
  1. Nature Publishing Group (43)
  2. Nature Research (42)
  3. Elsevier Inc. (35)
  4. American Society of Clinical Oncology (29)
  5. American Association for Cancer Research (21)
  6. John Wiley & Sons (16)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma
    Journal Article

    Travis, W. D.; Garg, K.; Franklin, W. A.; Wistuba, I. I.; Sabloff, B.; Noguchi, M.; Kakinuma, R.; Zakowski, M.; Ginsberg, M.; Padera, R.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    Journal Article

    Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • Hodgkin's lymphoma associated with plasma cell neoplasia: Cytological features and review of the literature
    Journal Article

    Oliai, B. R.; Zakowski, M. F.; Lin, O.
    Diagnostic Cytopathology (2005)

    Fulltext@MSK | Save
  • Cytological features of epithelioid mesenchymal neoplasms: A study of 21 cases
    Journal Article

    Lin, O.; Olgac, S.; Zakowski, M.
    Diagnostic Cytopathology (2005)

    Fulltext@MSK | Save
  • Exfoliative sputum cytology of cancers metastatic to the lung
    Journal Article

    Ali, T. Z.; Zakowski, M. F.; Yung, R. C. W.; Burroughs, F. H.; Ali, S. Z.
    Diagnostic Cytopathology (2005)

    Fulltext@MSK | Save
  • Analysis of EGFR/P13K signaling in bronchioloalveolar carcinoma progression and outcome
    Meeting Abstract

    Sarkaria, I. S.; Pham, D.; Talbot, S. G.; Hezel, M.; Patel, K. N.; Ebright, M. I.; Zakowski, M. F.; Chuai, S.; Memoli, N.; Miller, V. A.; more...
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Sputum analysis in lung cancer
    Meeting Abstract

    Zakowski, M. F.
    Lung Cancer (2004)

    Fulltext@MSK | Save
  • Molecular characteristics of non-small cell lung cancer (NSCLC) patients sensitive to gefitinib
    Meeting Abstract

    Pao, W.; Zakowski, M.; Cordon-Cardo, C.; Ben-Porat, L.; Kris, M. G.; Miller, V. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC)
    Meeting Abstract

    Kris, M. G.; Sandler, A.; Miller, V.; Cespon, M.; Zakowski, M.; Pizzo, B.; Venkatraman, E.; Gomez, J.; Johnson, D.; Carbone, D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save